Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase 2

Completed

• Conditions: Open-Angle Glaucoma; Ocular Hypertension

• Registration Number: NCT00465621
• Lead Sponsor: Alcon Research

Brief Summary

The purpose of thie study is to compare the safety and IOP-lowering efficacy of AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM to Xalatan dosed QD PM and Vehicle in patients with open-angle glaucoma or ocular hypertension

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03
• Study First Submitted: 2007-04-23
• Study First Submitted QC: 2007-04-23
• Study First Posted: 2007-04-25
• Primary Completion: 2007-07
• Status Verified: 2008-07
• Last Update Submitted: 2008-07-28
• Last Update Posted: 2008-07-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Open-angle glaucoma
• ocular hypertension

Exclusion Criteria

• VA worse than 0.60

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Mean IP Change from Baseline

Trial Locations

Locations (1)

Atlanta; 🇺🇸 Atlanta, Georgia, United States